BioForm Medical to Present at the 2008 JPMorgan Healthcare Conference on January 7, 2008
December 19 2007 - 1:00PM
PR Newswire (US)
SAN MATEO, Calif., Dec. 19 /PRNewswire-FirstCall/ -- BioForm
Medical, Inc. (NASDAQ:BFRM) today announced that Steven Basta,
Chief Executive Officer, will present a company overview at the
upcoming 26th Annual JPMorgan Healthcare Conference being held from
January 7-10, 2008. BioForm Medical's presentation will take place
on Monday, January 7th, 2008 at 8:30 a.m. PST (11:30 am EST) at the
Westin St. Francis Hotel in San Francisco, CA. A live and archived
copy of the webcast of BioForm Medical's presentation will be
available on the Investor Relations section of the company's
website at http://www.bioform.com/. Participants should allow
adequate time prior to the event to download any software necessary
for the webcast. About BioForm Medical, Inc.: BioForm Medical, Inc.
is a medical aesthetics company headquartered in San Mateo,
California. BioForm Medical is dedicated to bringing doctors and
their patients safe and effective products for use in the
dermatology, plastic surgery and ENT markets. BioForm Medical's
products include Radiesse(R) filler for use in facial aesthetics
and vocal fold insufficiency, and Coaptite(R) injectable implant
for treating female stress urinary incontinence which is marketed
through a partnership with Boston Scientific Corporation. BioForm
Medical has licensed U.S. marketing rights to Aethoxysklerol(R)
sclerotherapy agent, which is the leading worldwide sclerotherapy
agent and is currently being evaluated in a Phase III clinical
trial. BioForm Medical has also licensed BioGlue(R) surgical
adhesive product for plastic surgery applications, which is being
developed in a partnership with CryoLife, Inc. Forward-Looking
Statements: This press release contains forward-looking statements
within the meaning of the U.S. Private Securities Litigation Reform
Act of 1995. Specifically, statements concerning BioForm Medical's
ability to continue to grow demand for Radiesse and likelihood and
timing of future product introductions are forward-looking
statements within the meaning of the Safe Harbor. Forward-looking
statements are based on management's current, preliminary
expectations and are subject to risks and uncertainties, which may
cause BioForm Medical's actual results to differ materially from
the statements contained herein. Further information on potential
risk factors that could affect BioForm Medical's business and its
financial results are detailed in its prospectus as filed with the
Securities and Exchange Commission on November 6, 2007. Undue
reliance should not be placed on forward-looking statements,
especially guidance on future financial performance, which speaks
only as of the date they are made. BioForm Medical undertakes no
obligation to update publicly any forward-looking statements to
reflect new information, events or circumstances after the date
they were made, or to reflect the occurrence of unanticipated
events. Contact: Adam Gridley 650.286.4025 Vice President,
Corporate Development BioForm Medical, Inc. DATASOURCE: BioForm
Medical, Inc. CONTACT: Adam Gridley, Vice President, Corporate
Development of BioForm Medical, Inc., +1-650-286-4025 Web site:
http://www.bioformmedical.com/
Copyright
Bioform Medical (MM) (NASDAQ:BFRM)
Historical Stock Chart
From Jun 2024 to Jul 2024
Bioform Medical (MM) (NASDAQ:BFRM)
Historical Stock Chart
From Jul 2023 to Jul 2024